Skip to main content
SpringerLink
Log in

Human Papillomavirus and Oropharyngeal Cancer: What You Need to Know in 2009

  • Head and Neck Cancer
  • Published:
Current Treatment Options in Oncology Aims and scope Submit manuscript

Opinion statement

Oropharyngeal cancer has demonstrated a steady increase in incidence over the past 20 years in contrast to declining numbers of head and neck squamous cell carcinoma (HNSCC) overall. Recent evidence has found that high-risk strains of human papillomavirus (HPV) are the likely cause of the changing epidemiology of oropharyngeal cancer. HPV-associated oropharyngeal cancer has a molecular, epidemiological, and clinical profile that is distinct from non-HPV HNSCC. Clinicians managing oropharyngeal HNSCC need to be aware of differences in the HPV HNSCC population which may impact treatment outcomes. Testing of HNSCC tumor tissue for HPV using validated and precise techniques should be performed when feasible.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

Papers of particular interest, published recently, has been highlighted as: • Of importance •• Of major importance

  1. Ferlay J, Bray F, Pisani P, Parkin DM: Globocan 2002: Cancer Incidence and Mortality Worldwide. IARC Cancer Base No. 5, Version 2.0. Lyon, France: IARC; 2004

  2. Sheinin R: Viruses: causative agents of cancer. Laryngoscope 1975, 85:468–486

    Article  CAS  PubMed  Google Scholar 

  3. Lindeberg H, Fey SJ, Ottosen PD, Mose Larsen P: Human papilloma virus (HPV) and carcinomas of the head and neck. Clin Otolaryngol Allied Sci 1988, 13:447–454

    Article  CAS  PubMed  Google Scholar 

  4. Brandwein MS, Nuovo GS, Biller H: Analysis of prevalence of human papillomavirus in laryngeal carcinomas. Study of 40 cases using polymerase chain reaction and consensus primers. Ann Otol Rhinol Laryngol 1993, 102:309–313

    CAS  PubMed  Google Scholar 

  5. Park NH, Min BM, Li SL, et al.: Immortalization of normal oral human keratinocytes with type 16 human papillomavirus. Carcinogenesis 1991, 12:1627–1631

    Article  CAS  PubMed  Google Scholar 

  6. Schiffman M, Castle PE, Jeronimo J, et al.: Human papillomavirus and cervical cancer. Lancet 2007, 370:890–907

    Article  CAS  PubMed  Google Scholar 

  7. Doorbar J: Molecular biology of human papillomavirus infection and cervical cancer. Clin Sci 2006, 110:525–541

    Article  CAS  PubMed  Google Scholar 

  8. Mork J, Lie K, Glattre E, et al.: Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck. N Engl J Med 2001, 344:1125–1131

    Article  CAS  PubMed  Google Scholar 

  9. Herrero R, Castellsague X, Pawlita M, et al.: Human papillomavirus and oral cancer: the International Agency for Research on Cancer Multicenter Study. J Natl Can Inst 2003, 95:1772–1783

    Google Scholar 

  10. Kreimer AR, Clifford GM, Boyle P, Franceschi S: Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomarkers Prev 2005, 14:467–475

    Article  CAS  PubMed  Google Scholar 

  11. Begum S, Cao D, Gillison M, et al.: Tissue distribution of human papillomavirus 16 DNA integration in patients with tonsillar carcinoma. Clin Cancer Res 2005, 11:5694–5699

    Article  CAS  PubMed  Google Scholar 

  12. Califano J, van der Reit P, Westra W, et al.: Genetc progression model for head and neck cancer: implications for field cancerization. Cancer Res 1996, 56:2488–2492

    CAS  PubMed  Google Scholar 

  13. Weinberger PM, Yu Z, Haffty BG, et al.: Molecular classification identifies a subset of human papillomavirus-associated oropharyngeal cancers with favorable prognosis. J Clin Oncol 2006, 24:736–747

    Article  CAS  PubMed  Google Scholar 

  14. Rose BR, Li W, O’Brien CJ: Human papillomvirus: a cause of some head and neck cances? Med J Aust 2004, 181:415–416

    PubMed  Google Scholar 

  15. Shiboski CH, Schmidt BL, Jordan RC: Tongue and tonsil carcinoma: increasing trends in the U.S. population ages 20–44 years. Cancer 2005, 103:1843–1849

    Article  PubMed  Google Scholar 

  16. Sturgis EM, Cinciripini PM: Trends in head and neck cancer incidence in relation to smoking prevalence: an emerging epidemic of human papillomavirus-associated cancers? Cancer 2007, 110:1429–1435

    Article  PubMed  Google Scholar 

  17. Hammarstedt L, Lindquist D, Dahlstrand H, et al.: Human papillomavirus as a risk factor for the increase in incidence of tonsillar cancer. Int J Cancer 2006, 119:2620–2623

    Article  CAS  PubMed  Google Scholar 

  18. Anaya-Saavedra G, Ramirez-Amador V, Irigoyen-Camacho E, et al.: High association of human papillomavirus infection with oral cancer: a case–control study. Arch Med Res 2008, 39:189–197

    Article  CAS  PubMed  Google Scholar 

  19. Gillison ML, D’Souza G, Westra W, et al.: Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers. J Natl Cancer Inst 2008, 100:407–420

    Article  PubMed  Google Scholar 

  20. Psyrri A, DiMaio D: Human papillomavirus in cervical and head-and-neck cancer. Nature Clin Prac 2008, 5:24–31

    Article  CAS  Google Scholar 

  21. Goldenberg D, Begum S, Westra WH, et al.: Cystic lymph node metastasis in patients with head and neck cancer: an HPV-associated phenomenon. Head Neck 2008, 30:898–903

    Article  PubMed  Google Scholar 

  22. Fakhry C, Westra W, Li S, et al.: Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst 2008, 100:261–269

    Article  CAS  PubMed  Google Scholar 

  23. Nichols AC, Faquin WC, Westra WH, et al.: HPV-16 infection predicts treatment outcome in oropharyngeal squamous cell carcinoma. Otolaryngol Head Neck Surg 2009, 140:228–234

    Article  PubMed  Google Scholar 

  24. Klozar J, Kratochvil V, Salakova M, et al.: HPV status and regional metastasis in the prognosis of oral and oropharyngeal cancer. Eur Arch Otorhinolaryngol 2007, 20: Epub ahead of print

  25. Ragin CCR, Taioli E: Survival of squamous cell carcinoma of the head and neck in relation to human papillomavirus infection: review and meta-analysis. Int J Cancer 2007, 121:1813–1820

    Article  CAS  PubMed  Google Scholar 

  26. Settle K, Posner MR, Schumaker LM, et al.: Racial survival disparity in head and neck cancer results from low prevalence of human papillomavirus infection in black oropharyngeal cancer patients. Cancer Prev Res 2009, 2:OF1–6

    Google Scholar 

  27. Licitra L, Perrone F, Bossi P, et al.: High-risk human papillomavirus affects prognosis in patients with surgically treated oropharyngeal squamous cell carcinoma. J Clin Oncil 2006, 24:5630–5636

    Article  CAS  Google Scholar 

  28. Hafkamp HC, Manni JJ, Haesevoets A, et al.: Marked differences in survival rates between smokers and nonsmokers and HPV 16-associated tonsillar carcinomas. Int J Cancer 2008, 122:2656–2664

    Article  CAS  PubMed  Google Scholar 

  29. Westra WH, Taube JM, Poeta ML, et al.: Inverse relationship between human papillomavirus-16 infection and disruptive p53 gene mutations in squamous cell carcinoma of the head and neck. Clin Cancer Res 2008, 14:366–369

    Article  CAS  PubMed  Google Scholar 

  30. Pradier O, Christiansen H, Schmidberger H, et al.: Adjuvant radiotherapy after transoral laser microsurgery for advanced squamous cell carcinoma of the head and neck. Int J Radiat Oncol Biol Phy 2005, 63:1368–1377

    Article  Google Scholar 

  31. Begum S, Gillison ML, Ansari-Lari MA, et al.: Detection of human papillomavirus in cervical lymph nodes: a highly effective strategy for localizing site of tumor origin. Clin Cancer Res 2003, 9:6469–6475

    CAS  PubMed  Google Scholar 

  32. Roh JL, Kim JS, Lee JH, et al.: Utility of combined (18)F-fluorodeoxyglucose-positron emission tomography and computed tomography in patients with cervical metastases from unknown primary tumors. Oral Oncol 2009, 45:218–224

    Article  PubMed  Google Scholar 

  33. Koch WM, Bhatti N, Williams MF, Eisele DW: Oncologic rationale for bilateral tonsillectomy in head and neck squamous cell carcinoma of unknown primary source. Otolaryngol Head Neck Surg 2001, 124:331–333

    Article  CAS  PubMed  Google Scholar 

  34. Miller CS, Johnstone BM: Human papillomavirus as a risk factor for oral squamous cell carcinoma: a meta-analysis, 1982–1997. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2001, 91:622–635

    Article  CAS  PubMed  Google Scholar 

  35. Smith EM, Swarnavel S, Ritchie JM, et al.: Prevalence of human papillomavirus in the oral cavity/oropharynx in a large population of children and adolescents. Pediatr Infect Dis J 2007, 26:836–840

    Article  PubMed  Google Scholar 

  36. Giuliano AR, Harris R, Sedjo RL, et al.: Incidence, prevalence, and clearance of type-specific human papillomavirus infections: the Young Women’s Health Study. J Infect Dis 2002, 186:462–469

    Article  PubMed  Google Scholar 

  37. Giuliano AR, Lu B, Nielson CM, et al.: Age-specific prevalence, incidence, and duration of human papillomavirus infections in a cohort of 290 US men. J Infet Dis 2008, 198:827–835

    Article  Google Scholar 

  38. Garland SM, Hernandez-Avila M, Wheeler CM, et al.: Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases. N Engl J Med 2007, 356:1928–1943

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Otolaryngology, Head and Neck Surgery, Medical University of South Carolina, 135 Rutledge Avenue MSC 550, Charleston, SC, 29425-5500, USA

    M. Boyd Gillespie MD, MS, Semyon Rubinchik PhD, Brian Hoel PhD & Natalie Sutkowski PhD

  2. MUSC Hollings Cancer Center Head and Neck Tumor Program, Medical University of South Carolina, Charleston, SC, USA

    M. Boyd Gillespie MD, MS

Authors
  1. M. Boyd Gillespie MD, MS
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Semyon Rubinchik PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Brian Hoel PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Natalie Sutkowski PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M. Boyd Gillespie MD, MS.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gillespie, M.B., Rubinchik, S., Hoel, B. et al. Human Papillomavirus and Oropharyngeal Cancer: What You Need to Know in 2009. Curr. Treat. Options in Oncol. 10, 296–307 (2009). https://doi.org/10.1007/s11864-009-0113-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11864-009-0113-5

Keywords

Search

Navigation